Iron chelation therapy in transfusion dependent patients with myelodysplastic syndrome with transfusional iron-overload in routine clinical management - interim analysis of the non-interventional study EXSEPT

被引：0
|
作者：
Nolte, F. [1 ]
Rubanov, O. [2 ]
Kuehn, R-B
Schumann, C. [1 ]
Kreil, S. [1 ]
Metzgeroth, G. [1 ]
Junkes, A. [3 ]
Johr, C. [3 ]
Albrecht, S. [3 ]
Hofmann, W-K [1 ]
机构：
[1] Univ Med Mannheim, Mannheim, Germany
[2] Off Based Hematol Oncol Specialist, Hamein, Germany
[3] Novartis Pharma GmbH, Nurnberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P770
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [41] A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox in Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R2 MRI
    Min, Yoo-Hong
    Kim, Hyeoung Joon
    Lee, Kyoo Hyung
    Yoon, Sung-Soo
    Lee, Jae Hoon
    Park, Hee-Sook
    Kim, Jin Seok
    Kim, Ho Young
    Shim, Hyeok
    Seong, Chu-Myong
    Kim, Chul Soo
    Chung, Jooseop
    Hyun, Myung Soo
    Jo, Deog-Yeon
    Jung, Chul Won
    Sohn, Sang Kyun
    Yoon, Hwi-Jong
    Kim, Byung Soo
    Joo, Young-Don
    Park, Chi-Young
    Cheong, June-Won
    BLOOD, 2008, 112 (11) : 1249 - 1249
  • [42] A multi-center, open label study evaluating the efficacy of iron chelation therapy with deferasirox in transfusional iron overload patients with myelodysplastic syndromes or aplastic anemia using quantitative R2 MRI
    Min, Y.
    Cheong, J.
    Kim, H.
    Lee, K.
    Yoon, S.
    Lee, J.
    Park, H.
    Kim, H.
    Shim, H.
    Seung, C.
    Kim, C.
    Chung, J.
    Hyun, M.
    Jo, D.
    Jung, C.
    LEUKEMIA RESEARCH, 2009, 33 : S118 - S119
  • [43] A Multi-Center, Open Label Study Evaluating the Efficacy, of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R2 mri
    Min, Yoo-Hong
    Kim, Hyeoung Joon
    Lee, Kyoo-Hyung
    Lee, Jae Hoon
    Park, Hee-Sook
    Kim, Jin Seok
    Shim, Hyeok
    Seung, Chu-Myung
    Kim, Chul Soo
    Chung, Jooseop
    Hyun, Myung Soo
    Jo, Deog-Yeon
    Jung, Chul Won
    Sohn, Sang Kyun
    Yoon, Hwi-Joong
    Kim, Byung Soo
    Joo, Young-Don
    Park, Chi-Young
    BLOOD, 2010, 116 (21) : 489 - 489
  • [44] Iron Chelation Therapy with Deferasirox In Transfusion Dependent Myelodysplastic Syndrome Patients. Preliminary Report From the Prospective MDS0306 GIMEMA Trial
    Angelucci, Emanuele
    Santini, Valeria
    Di Tucci, Anna Angela
    Della Casa, Chiara
    Finelli, Carlo
    Volpe, Antonio
    Pogliani, Enrico Maria
    Quarta, Giovanni
    Levis, Alessandro
    D'Arco, Alfonso Maria
    Saglio, Giuseppe
    Cascavilla, Nicola
    Morra, Enrica
    Vallisa, Daniele
    Foa, Robin
    Leone, Giuseppe
    Storti, Sergio
    Gabbas, Attilio
    Annino, Luciana
    Magro, Domenico
    Tosi, Patrizia
    Caocci, Giovanni
    Musto, Pellegrino
    Amadori, Sergio
    Leoni, Pietro
    Gobbi, Marco
    Piciocchi, Alfonso
    Vignetti, Marco
    Porcedda, Serenella
    Tura, Sante
    BLOOD, 2010, 116 (21) : 1206 - 1206
  • [45] Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy
    Efficace, Fabio
    Santini, Valeria
    La Nasa, Giorgio
    Cottone, Francesco
    Finelli, Carlo
    Borin, Lorenza
    Quaresmini, Giulia
    Di Tucci, Anna Angela
    Volpe, Antonio
    Cilloni, Daniela
    Quarta, Giovanni
    Sanpaolo, Grazia
    Rivellini, Flavia
    Salvi, Flavia
    Molteni, Alfredo
    Voso, Maria Teresa
    Alimena, Giuliana
    Fenu, Susanna
    Mandelli, Franco
    Angelucci, Emanuele
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2016, 6 (01) : 80 - 88
  • [46] High Rate of Erythroid Response During Iron Chelation Therapy in a Cohort of 105 Patients Affected by Hematologic Malignancies with Transfusional Iron Overload: An Italian Multicenter Retrospective Study
    Cilloni, Daniela
    Messa, Emanuela
    Biale, Lucia
    Bonferroni, Margherita
    Salvi, Flavia
    Lunghi, Monia
    Allione, Bernardino
    Ferrero, Dario
    Freilone, Roberto
    Levis, Alessandro
    Saglio, Giuseppe
    BLOOD, 2011, 118 (21) : 280 - 281
  • [47] Development of an adherence to Iron-Chelation Therapy measure through a qualitative study: patient and caregiver perspectives in transfusion-dependent anemias and myelodysplastic syndrome
    Lasch, Kathryn E.
    Horodniceanu, Erica G.
    Bal, Vasudha
    Cote, Isabelle
    Dorgan, Amy
    Malet, Isabelle
    QUALITY OF LIFE RESEARCH, 2014, 23 : 105 - 105
  • [48] Cost-effectiveness analysis of oral iron chelation therapy with deferasirox (Exjade®, ICL670) versus infusional chelation therapy with deferoxamine in patients with transfusion-dependent myelodysplastic
    Delea, TE
    Thomas, SK
    Baladi, JF
    Phatak, PD
    BLOOD, 2005, 106 (11) : 484B - 485B
  • [49] Mogamulizumab in patients with mycosis fungoides or Sezary syndrome: interim analysis of the German non-interventional MINT study
    Assaf, Chalid
    Booken, Nina
    Dippel, Edgar
    Garzarolli, Marlene
    Haferkampt, Sebastian
    Schlaak, Max
    Dobos, Gabor
    Ocker, Lennart
    Terheyden, Patrick
    Klemke, Claus-Detlev
    Nicolay, Jan
    Wobser, Marion
    Wohlrab, Johannes
    Bachinger, Andreas
    Danish, Azeem
    Jadasz, Janusz
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S20 - S21
  • [50] AN ONGOING EUROPEAN NON-INTERVENTIONAL REGISTRY STUDY OF PATIENTS WITH LENNOX-GASTAUT SYNDROME: INTERIM ANALYSIS
    Nikanorova, M.
    Chouette, I.
    EPILEPSIA, 2012, 53 : 219 - 219
12345